APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 82 filers reported holding APTEVO THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $106,000 | -88.3% | 180,149 | -82.4% | 0.01% | -88.3% |
| Q2 2019 | $906,000 | -1.5% | 1,021,836 | 0.0% | 0.10% | -19.5% |
| Q1 2019 | $920,000 | -29.1% | 1,021,836 | 0.0% | 0.13% | -30.4% |
| Q4 2018 | $1,298,000 | -63.8% | 1,021,836 | +44.6% | 0.18% | -60.7% |
| Q3 2018 | $3,590,000 | +38.4% | 706,613 | +35.9% | 0.47% | +77.3% |
| Q2 2018 | $2,594,000 | -58.7% | 519,894 | -72.9% | 0.26% | -60.4% |
| Q1 2018 | $6,280,000 | -9.0% | 1,920,368 | +18.0% | 0.67% | -19.1% |
| Q4 2017 | $6,903,000 | +57.0% | 1,628,053 | -15.2% | 0.82% | +70.2% |
| Q3 2017 | $4,398,000 | +10.6% | 1,920,368 | 0.0% | 0.48% | -2.6% |
| Q2 2017 | $3,975,000 | +0.5% | 1,920,368 | 0.0% | 0.50% | -20.7% |
| Q1 2017 | $3,956,000 | -15.6% | 1,920,368 | 0.0% | 0.63% | -28.8% |
| Q4 2016 | $4,686,000 | +87.8% | 1,920,368 | +97.1% | 0.88% | +59.3% |
| Q3 2016 | $2,495,000 | – | 974,492 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,179,131 | $2,735,000 | 1.91% |
| Worth Venture Partners, LLC | 375,669 | $246,000 | 0.12% |
| Fondren Management LP | 120,184 | $79,000 | 0.08% |
| Park West Asset Management LLC | 1,000,000 | $654,000 | 0.03% |
| Point72 Asset Management, L.P. | 2,450,000 | $1,604,000 | 0.01% |
| ATLAS CAPITAL ADVISORS LLC | 49,045 | $32,099,000 | 0.01% |
| Alyeska Investment Group, L.P. | 750,000 | $491,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 78,000 | $51,000 | 0.00% |
| ALGERT GLOBAL LLC | 20,556 | $13,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 540,057 | $354,000 | 0.00% |